S 3021
Gluten in Medicine Disclosure Act of 2019
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Gluten in Medicine Disclosure Act of 2019, requires drug manufacturers to clearly label medications that contain ingredients derived from gluten-containing grains like wheat, barley, or rye. The labels must explicitly state that the drug contains these ingredients and identify the specific grain source. This aims to inform patients with celiac disease or gluten sensitivities about potential allergens in their medications. The law will take effect either two years after the bill’s passage or a date determined by the Secretary of Health and Human Services.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.